TIRYAQ-E-ARBA (A POLY HERBAL UNANI FORMULATION) IN FIGHTING AGAINST COVID 19 LIKE CONDITIONS – UNANI PERSPECTIVE

Nafisa Qibriya Khan, A. H. Farooqui, S. Fatima, J. Ahmad, Tausif S. Khan
{"title":"TIRYAQ-E-ARBA (A POLY HERBAL UNANI FORMULATION) IN FIGHTING AGAINST COVID 19 LIKE CONDITIONS – UNANI PERSPECTIVE","authors":"Nafisa Qibriya Khan, A. H. Farooqui, S. Fatima, J. Ahmad, Tausif S. Khan","doi":"10.53390/ijum.v13i1.3","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is a pandemic disease of modern time with unique and rapid transmission rate and affected almost all the nations without respecting any border. Coronavirus disease 2019 (COVID-19) is arguably the biggest health crisis the world has faced in 21st century. It is an infectious disease and declared pandemic by the World Health Organization. The coronavirus disease 2019 (COVID-19) outbreak, which originated in Wuhan, China, has now spread to 192 countries and administrative regions infecting nearly 800,000 individuals of all ages as of 31 March 2020. Though most infected individuals exhibit mild symptoms including fever, upper respiratory tract symptoms, shortness of breath, and diarrhoea, or are asymptomatic altogether, severe cases of infection can lead to pneumonia, multiple organ failure, and death. Globally, at least 7900 deaths have been directly attributed to COVID19, and this number is expected to rise with the ongoing epidemic. This is particularly crucial as the current outbreak involves a new pathogen (SARS-CoV-2), on which limited knowledge exists of its infectivity and clinical profile. Research is in progress on therapeutic efficacy of various agents including anti-malarials (Chloroquine and Hydroxychloroquine), antiviral drugs, and convalescent serum of recovered patients. Unani system of medicine is one of the traditional systems of medicine which is being explored for providing preventive, supportive and rehabilitative care to patients. Unani system of medicine has a detailed description of drugs that are utilized in many infectious diseases, including respiratory infections. Immune response is essential to eliminate virus and to preclude disease progression to severe stages. Therefore, it is important to summarize the evidence regarding the preventive measures, control options such as immune-stimulator and prophylactic treatment in Unani medicine against Covid19. This review summarizes various pharmacological actions of Unani formulation Tiryaq-e-Arba in Unani literature and various reported pharmacological activities which can possibly provide prevention, control and reduction of complications of this deadly disease.","PeriodicalId":13351,"journal":{"name":"Indian Journal of Unani Medicine","volume":"57 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Unani Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53390/ijum.v13i1.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Coronavirus disease 2019 (COVID-19) is a pandemic disease of modern time with unique and rapid transmission rate and affected almost all the nations without respecting any border. Coronavirus disease 2019 (COVID-19) is arguably the biggest health crisis the world has faced in 21st century. It is an infectious disease and declared pandemic by the World Health Organization. The coronavirus disease 2019 (COVID-19) outbreak, which originated in Wuhan, China, has now spread to 192 countries and administrative regions infecting nearly 800,000 individuals of all ages as of 31 March 2020. Though most infected individuals exhibit mild symptoms including fever, upper respiratory tract symptoms, shortness of breath, and diarrhoea, or are asymptomatic altogether, severe cases of infection can lead to pneumonia, multiple organ failure, and death. Globally, at least 7900 deaths have been directly attributed to COVID19, and this number is expected to rise with the ongoing epidemic. This is particularly crucial as the current outbreak involves a new pathogen (SARS-CoV-2), on which limited knowledge exists of its infectivity and clinical profile. Research is in progress on therapeutic efficacy of various agents including anti-malarials (Chloroquine and Hydroxychloroquine), antiviral drugs, and convalescent serum of recovered patients. Unani system of medicine is one of the traditional systems of medicine which is being explored for providing preventive, supportive and rehabilitative care to patients. Unani system of medicine has a detailed description of drugs that are utilized in many infectious diseases, including respiratory infections. Immune response is essential to eliminate virus and to preclude disease progression to severe stages. Therefore, it is important to summarize the evidence regarding the preventive measures, control options such as immune-stimulator and prophylactic treatment in Unani medicine against Covid19. This review summarizes various pharmacological actions of Unani formulation Tiryaq-e-Arba in Unani literature and various reported pharmacological activities which can possibly provide prevention, control and reduction of complications of this deadly disease.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从unani的角度来看,Tiryaq-e-arba(一种多草药unani制剂)可用于对抗类似covid - 19的疾病
2019冠状病毒病(COVID-19)是一种传播速度独特、传播速度快的现代大流行疾病,几乎不分国界,影响到所有国家。2019冠状病毒病(COVID-19)可以说是21世纪世界面临的最大健康危机。它是一种传染病,被世界卫生组织宣布为大流行。2019冠状病毒病(COVID-19)疫情起源于中国武汉,截至2020年3月31日,疫情已蔓延至192个国家和行政区域,感染了近80万各年龄段的人。虽然大多数感染者表现出轻微症状,包括发烧、上呼吸道症状、呼吸短促和腹泻,或完全无症状,但严重感染病例可导致肺炎、多器官衰竭和死亡。在全球范围内,至少有7900人的死亡直接归因于covid - 19,随着疫情的持续,这一数字预计还会上升。这一点尤其重要,因为目前的疫情涉及一种新的病原体(SARS-CoV-2),而对其传染性和临床特征的了解有限。目前正在研究各种药物的治疗效果,包括抗疟疾药物(氯喹和羟氯喹)、抗病毒药物和康复患者的恢复期血清。Unani医学系统是传统医学系统之一,正在探索为病人提供预防、支助和康复护理。Unani医学系统详细描述了用于治疗包括呼吸道感染在内的许多传染病的药物。免疫反应对于消除病毒和防止疾病发展到严重阶段至关重要。因此,重要的是总结有关预防措施的证据,免疫刺激剂和预防治疗等控制方案。本文综述了乌纳尼制剂Tiryaq-e-Arba在乌纳尼文献中的各种药理作用以及各种已报道的可能预防、控制和减少这一致命疾病并发症的药理作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
DEODAR (CEDRUS DEODARA (ROXB.) LOUD.): THERAPEUTIC USES AND PHARMACOLOGICAL STUDIES-A REVIEW ETHNOBOTANY, PHARMACOLOGICAL APPLICATION, PHYTOCHEMISTRY AND THERAPEUTIC POTENTIAL OF BLACK PEPPER (PIPER NIGRUM L.): AN UPDATED REVIEW AN OVERVIEW ON THE PHARMACOLOGICAL ACTIVITIES OF Myrtus Communis L. UNANI ASPECT OF HEALTH AND DISEASES UNANI ASPECT OF HEALTH AND DISEASES
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1